Advanced technologies such as artificial intelligence (AI) and 3D printing are reshaping the future of personalised healthcare. By enabling more precise, patient-specific interventions, these innovations are redefining what’s possible in delivering more targeted and effective healthcare interventions. As these fields evolve, robust quality and regulatory frameworks are critical to translating these breakthroughs safely and effectively into improved patient outcomes.

Dr Naomi Paxton is a MedTech innovator. She is currently the Research & Operations Lead at Propel Health AI, a Brisbane-based startup and Australia’s first end-to-end healthcare data and AI platform, where she supports the development of AI-powered tools for clinical decision-making, real-world evidence generation, and healthcare system transformation. Previously, Dr Naomi Paxton was a Senior Research Fellow at QUT and led the Bioinspired Additive Manufacturing (BioAM) group. With a background in physics, Naomi completed the dual international Biofabrication Masters degree and has completed her research training in world-leading international labs in Australia, Germany, the UK and USA.

Dr Paxton is also a multi-award winning science communicator, dual TEDx speaker, and passionate advocate for diversity in STEM. For Naomi's commitment to STEM outreach & engagement, and in particularly supporting Women in STEM, Naomi was awarded QUT's overall Student Leader of the Year. Naomi was also the inaugural winner of the ATSE Ezio Rizzardo award, recipient of the QLD Women in Technology's Life Sciences Young Achiever Award, CSIRO Alumni Scholarship in Physics.